[Type IV anaphylactic reaction and ST-elevation acute coronary syndrome due to coronary vasospasm secondary to administration of cisatracurium].
M F
MF
Benítez Morillo
M
M
Casares Vivas
F J
FJ
Tejada Ruiz
J M
JM
Narváez Bermejo
D054058:Acute Coronary Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000145:classification; D001279:Atracurium / Q000009:adverse effects / Q000031:analogs & derivatives*; D003329:Coronary Vasospasm / Q000150:complications*; D005260:Female; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*
D009466:Neuromuscular Blocking Agents; D001279:Atracurium; C101584:cisatracurium